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Abstract
Background: Several genetic variants in the ATP-binding cassette transporter A1 (ABCA1) gene have associated
with modifications of serum high-density lipoprotein cholesterol (HDL-C) levels and the susceptibility for coronary
heart disease, but the findings are still controversial in diverse racial/ethnic groups. Bai Ku Yao is an isolated
subgroup of the Yao minority in southern China. The present study was undertaken to detect the possible
association of V825I (rs2066715) polymorphism in the ABCA1 gene and several environmental factors with serum
lipid levels in the Guangxi Bai Ku Yao and Han populations.
Methods: A total of 677 subjects of Bai Ku Yao and 646 participants of Han Chinese were randomly selected from
our previous stratified randomized cluster samples. Polymerase chain reaction and restriction fragment length
polymorphism assay combined with gel electrophoresis were performed for the genotyping of V825I variant, and
then confirmed by direct sequencing.
Results: The levels of serum total cholesterol (TC), HDL-C, apolipoprotein (Apo) AI and ApoB were lower in Bai Ku
Yao than in Han (P < 0.01 for all). The frequency of G and A alleles was 57.4% and 42.6% in Bai Ku Yao, and 57.7%
and 42.3% in Han (P > 0.05); respectively. The frequency of GG, GA and AA genotypes was 33.7%, 47.4% and 18.9%
in Bai Ku Yao, and 33.4%, 48.6% and 18.0% in Han (P > 0.05); respectively. There was no difference in the genotypic
and allelic frequencies between males and females in the both ethnic groups. The subjects with AA genotype in
Bai Ku Yao had higher serum TC levels than the subjects with GG and GA genotypes (P < 0.05). The participants
with AA genotype in Han had lower serum HDL-C and ApoAI levels than the participants with GG and GA
genotypes (P < 0.05 for each), but these results were found in males but not in females. Multivariate linear
regression analysis showed that the levels of TC in Bai Ku Yao and HDL-C and ApoAI in male Han were correlated
with genotypes (P < 0.05 for all). Serum lipid parameters were also correlated with sex, age, body mass index,
alcohol consumption, and blood pressure in both ethnic groups (P < 0.05-0.001).
Conclusion: The present study suggests that the V825I polymorphism in the ABCA1 gene is associated with male
serum HDL-C and ApoAI levels in the Han, and serum TC levels in the Bai Ku Yao populations. The difference in
the association of V825I polymorphism and serum lipid levels between the two ethnic groups might partly result
from different ABCA1 gene-enviromental interactions.
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Human and animal model studies have confirmed that
abnormal lipid metabolism leads to kinds of diseases,
especially altered lipoprotein levels are crucial risk fac-
tors for atherosclerosis [1]. A number of studies have
established that elevated concentrations of plasma high-
density lipoprotein cholesterol (HDL-C) and lower low-
density lipoprotein cholesterol (LDL-C) levels reduce
the risk for coronary heart disease (CHD) [2-5], but the
causality of this inverse association is still incompletely
known. There are multiple mechanisms by which HDL-
C can be cardioprotective and LDL-C inducing athero-
genesis. A widely accepted view is that HDL-C is ather-
oprotective because of its role in reverse cholesterol
transport, a metabolic pathway whereby excess choles-
terol in peripheral tissues is transported to the liver for
preventing detrimentally accumulation in body [6,7]. It
is estimated that up to 60% of the interindividual varia-
tion in plasma HDL-C and LDL-C levels is due to
genetic variation [8-11], and that the major portion of
this variation is polygenic attributable to sequence varia-
tion in various loci. It would be interesting to assess the
possible association between particular gene variants
and serum lipid profiles in the general population.
The ATP-binding cassette transporter A1 (ABCA1) is
a member of the large ATP binding cassette transpor-
ters family, which comprises proteins translocating a
wide variety of substrates across cell membranes utilis-
ing ATP [12]. It has been suggested that ABCA1 partici-
pates in the efflux of free cholesterol from peripheral
cells, including macrophage-derived foam cells, and con-
tributes to the formation of mature HDL by facilitating
the lipidation of circulating nascent apolipoprotein
(Apo) AI particles with free cholesterol at the plasma
membrane [13-15]. Loss-of-function mutations in the
ABCA1 gene cause Tangier disease, a rare genetic disor-
der characterized by near absence of HDL and accumu-
lation of lipids within cells in various tissues including
the blood vessel wall [16-19]. ABCA1 mutation carriers
have markedly higher incidence of CHD compared with
non-carriers [20]. In addition, in families of Tangier dis-
ease patients, onset of CHD is significantly earlier in
mutation carriers than in noncarriers [21,22]. These
results suggest that functional deficiency of ABCA1
could also induce an atherogenic decrease in HDL-C
levels, incriminating the ABCA1 gene as a candidate for
atherosclerotic complications in the general population
[23-25]. A number of single nucleotide polymorphisms
(SNPs) have been identified both in the coding and pro-
moter regions of the ABCA1 gene http://www.ncbi.nlm.
n i h . g o v / S N P / .H o w e v e r ,f o rm o s to ft h e mt h e r ea r en o
robust data about their functional relevance. A common
variant of V825I in the ABCA1 gene is a missense SNP
in the exon 17 that locates in the middle part of the
protein corresponding to sixth transmembrane a-helix
with mutation of GTC®ATC. The ABCA1 V825I poly-
morphism has been found to be associated with modifi-
cations of serum HDL-C levels in some studies [26-29]
but not in others [30-33]. Thus, it would be interesting
to evaluate whether common genetic variations in the
gene constitute a major source of interindividual varia-
bility in serum lipid levels and CHD susceptibility in the
different ethinc populations.
Han is the largest ethnic group and Yao is the ele-
venth largest minority among the 55 minority groups in
China according to the population size. Bai Ku Yao
(White-trouser Yao, all of men wear white knee-length
knickerbockers) is an isolated branch of the Yao minor-
ity with the population size about 30000. Because of iso-
lation from the other ethnic groups, the special customs
and cultures including their clothing, intra-ethnic mar-
riages, dietary habits, and life style are still completely
preserved to the present day. In several previous epide-
miological studies, we showed that several serum lipid
parameters were lower in Bai Ku Yao than in Han Chi-
nese from the same region [34,35]. This ethnic differ-
ence in serum lipid profiles remains unknown. We
hypothesized that some genetic factors may be different
between the two ethnic groups. Therefore, the aim of
the present study was to detect the association of V825I
polymorphism in the ABCA1 gene and several environ-
mental factors with serum lipid phenotypes in the
Guangxi Bai Ku Yao and Han populations.
Materials and methods
Study population
A total of 677 participants of Bai Ku Yao and 646 sub-
jects of Han were randomly selected from our previous
randomized cluster samples [34,35]. All of them come
from both Lihu and Baxu villages in Nandan County,
Guangxi Zhuang Autonomous Region, People’s Republic
of China. They were undergone routine physical exami-
nation and appropriate laboratory tests. Ages of the Bai
Ku Yao subjects ranged from 15 to 80 years, the average
age was 39.74 ± 16.01 years old. There were 324 males
(47.86%) and 353 females (52.14%). The mean age of the
Han subjects was 41.29 ± 16.39 years (range 15 to 80).
There were 315 men (48.76%) and 331 women (51.24%).
Both the Han and Bai Ku Yao subjects had no evidence
of any chronic illness, including hepatic, renal, or thyr-
oid. The participants with a history of heart attack or
myocardial infarction, stroke, congestive heart failure,
diabetes or fasting blood glucose ≥ 7.0 mmol/L deter-
mined by glucose meter were also excluded. The partici-
pants were not taking medications known to affect
serum lipid levels (lipid-lowering drugs such as statins
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Page 2 of 14or fibrates, beta-blockers, diuretics, or hormones). The
present study was approved by the Ethics Committee of
the First Affiliated Hospital, Guangxi Medical University.
Informed consent was obtained from all participants.
Epidemiological survey
The epidemiological survey was carried out under inter-
nationally standardized methods by following a general
protocol [36]. Common information on demographics,
socioeconomic status, and lifestyle factors of the partici-
pants was collected by answering all the detailed ques-
tions of a standardized questionnaire. The data of
alcohol consumption included questions about the
number of liangs (about 50 g) of rice wine, corn wine,
r u m ,b e e r ,o rl i q u o rc o n s u m e dd u r i n gt h ep r e c e d i n g
12 months. Alcohol consumption was categorized
into groups of grams of alcohol per day: <25 and ≥ 25.
Smoking status was divided into groups of cigarettes per
day: <20 and ≥ 20. Several parameters such as height,
weight, and waist circumference were measured. Sitting
blood pressure was measured three times with the use
of a mercury sphygmomanometer after a 5-min rest,
and the average of the three measurements was used for
the level of blood pressure. Systolic blood pressure was
determined by the first Korotkoff sound, and diastolic
blood pressure by the fifth Korotkoff sound. Body
weight, to the nearest 50 grams, was measured using a
portable balance scale. Subjects were weighed without
shoes and in a minimum of clothing. Height was mea-
sured, to the nearest 0.5 cm, using a portable steel mea-
suring device. From these two measurements body mass
index (BMI, kg/m
2) was calculated.
Biochemical analyses
Venous blood sample (8 mL) was obtained from each
subject between 8 and 11 AM, after 12 hours of fasting.
A part of the sample (3 mL) was collected into glass
t u b ea n du s e dt od e t e r m i n es e r u ml i p i dl e v e l s .T h e
remaining of the sample (5 mL) was transferred to tubes
with anticoagulate solution (4.80 g/L citric acid, 14.70 g/
L glucose, and 13.20 g/L tri-sodium citrate) and used to
extract DNA. The levels of serum total cholesterol (TC),
triglyceride (TG), HDL-C, and LDL-C in samples were
detected by enzymatic methods with commercially avail-
able kits, Tcho-1, TG-LH (RANDOX Laboratories Ltd.,
Ardmore, Diamond Road, Crumlin Co. Antrim, United
Kingdom, BT29 4QY), Cholestest N HDL, and Cholest-
est LDL (Daiichi Pure Chemicals Co., Ltd., Tokyo,
Japan), respectively. Serum ApoAI and ApoB levels were
detected by the immunoturbidimetric immunoassay
using a commercial kit (RANDOX Laboratories Ltd.).
All determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical
Science Experiment Center of the First Affiliated Hospi-
tal, Guangxi Medical University.
DNA amplification and genetic analysis
Genomic DNA from peripheral blood leukocytes was
extracted using the phenol-chloroform method [37-42].
To detect the genetypes, a polymerase chain reaction
and restriction fragment length polymorphism (PCR-
RFLP) assay was developed [29]. Each 25 μL PCR ampli-
cation mixture contained 5-200 ng DNA, 10 × PCR
buffer (1.8 mM MgCl2)2 . 5μL, 1 U Taq polymerase, 2.5
mmol/L of each dNTP (Tiangen, Beijing, People’s
Republic of China) 2.0 μL, 5 pmol/L of each primer
(0.5 μL). The paired primer sequences were: forward,
5’-GGTAGCCCACCACTCCCCTAAAG-3’;r e v e r s e ,
5’-ATCAGCTGCCTGTCCTTGGACTA-3’ (Sangon,
Shanghai, People’s Republic of China). The PCR amplifi-
cation reaction was under a cycling protocol of proces-
sing started with 95°C for 5 min; and 30 cycles at 94°C
for 30 s, 58°C for 45 s and 72°C for 30 s and a final
extension at 72°C for 5 min were followed. RFLP assay
was performed using 10 U of the appropriate restriction
enzyme Tag1p e r1 0μL PCR products and incubated at
65°C for 1-16 hours as the manufacture described. The
genotypes were identified by electrophoresis on 2% agar-
ose gels and visualized with ethidium-bromide staining,
ultraviolet illumination. Genotypes were scored by an
experienced reader blinded to epidemiological data and
serum lipid levels. Six samples (GG, GA and AA geno-
types in two; respectively) detected by the PCR-RFLP
were also confirmed by sequencing directly. The PCR
products were purified by low melting point gel electro-
phoresis and phenol extraction, and then the DNA
sequences were analyzed in Shanghai Sangon Biological
Engineering Technology & Services Co., Ltd., People’s
Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI and ApoB levels, and the ratio of ApoAI to
ApoB in our Clinical Science Experiment Center were
3.10-5.17, 0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-
1.78, 0.63-1.14 g/L, and 1.00-2.50; respectively. The indi-
viduals with TC >5.17 mmol/L and/or TG >1.70 mmol/
L were defined as hyperlipidemic [34,35]. Hypertension
was diagnosed according to the criteria of 1999 World
Health Organization-International Society of Hyperten-
sion Guidelines for the management of hypertension
[43,44]. The diagnostic criteria of overweight and obesity
were according to the Cooperative Meta-analysis Group
of China Obesity Task Force. Normal weight, over-
weight and obesity were defined as a BMI <24, 24-28,
and >28 kg/m
2; respectively [45].
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Epidemiological data were recorded on a pre-designed
form and managed with Excel software. All statistical
analyses were done with the statistical software package
SPSS 17.0 (SPSS Inc., Chicago, Illinois). Quantitative
variables were expressed as mean ± standard deviation
(serum TG levels were presented as medians and inter-
quartile ranges). Qualitative variables were expressed as
percentages. Allele frequency was determined via direct
counting, and the standard goodness-of-fit test was used
to test the Hardy-Weinberg equilibrium. Difference in
genotype distribution between the groups was obtained
using the chi-square test. The difference in general char-
acteristics between Bai Ku Yao and Han was tested by
the Student’su n p a i r e dt-test. The association of geno-
types and serum lipid parameters was tested by analysis
of covariance (ANCOVA). Se x ,a g e ,B M I ,b l o o dp r e s -
sure, alcohol consumption, cigarette smoking were
adjusted for the statistical analysis. Multivariate linear
regression analysis with stepwise modeling was per-
formed to evaluate the association of serum lipid levels
with genotypes (GG = 1, GA = 2 and AA = 3) and sev-
eral environment factors in the combined population of
Bai Ku Yao and Han, Bai Ku Yao, Han, males, and
females; respectively. A P v a l u eo fl e s st h a n0 . 0 5w a s
considered statistically significant.
Results
General characteristics and serum lipid levels
The general characteristics and serum lipid levels
between the Bai Ku Yao and Han populations are sum-
marised in Table 1. The levels of height, weight, BMI,
systolic blood pressure, pulse pressure, serum TC, HDL-
C, ApoAI and ApoB were lower in Bai Ku Yao than in
Han (P < 0.05-0.001), whereas the percentages of sub-
jects who consumed alcohol were higher in Bai Ku Yao
than in Han (P <0 . 0 0 1 ) .T h e r ew e r en os i g n i f i c a n td i f -
ferences in the levels of diastolic blood pressure, serum
T G ,L D L - C ,t h er a t i oo fA p o A It oA p o B ,a g es t r u c t u r e ,
the percentage of subjects who smoked cigarettes, or the
ratio of male to female between the two ethnic groups
(P > 0.05 for all).
Electrophoresis and genotypes
After the genomic DNA of the samples was amplified by
PCR and imaged by 2% agarose gel electrophoresis, the
purpose gene of 525 bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when a G to A transversion at
825 locus of the ABCA1 gene. The presence of the cut-
ting site indicates the A allele, while its absence indicates
the G allele (cannot be cut). Thus, the GG genotype is
Table 1 The general characteristics and serum lipid levels between the Bai Ku Yao and Han populations
Parameter Bai Ku Yao Han Chinese t (c
2) P
Number 677 646 - -
Male/female 324/353 315/331 0.108 0.783
Age (years) 39.74 ± 16.01 41.29 ± 16.39 -1.734 0.083
Body mass index (kg/m
2) 22.08 ± 2.39 22.40 ± 3.15 -2.082 0.038
Systolic blood pressure (mmHg) 118.6 ± 17.01 121.70 ± 16.72 -3.294 0.001
Diastolic blood pressure (mmHg) 75.18 ± 9.64 76.27 ± 10.86 -1.936 0.053
Pulse pressure (mmHg) 43.46 ± 12.69 45.44 ± 10.97 -3.026 0.003
Cigarette smoking [n (%)]
Nonsmoker 477 (70.5) 458 (70.5)
<20 cigarettes/day 93 (13.0) 84 (13.7)
≥ 20 cigarettes/day 107 (16.1) 104 (15.8) 0.160 0.923
Alcohol consumption [n (%)]
Nondrinker 386 (57.0) 406 (62.8)
<25 g/day 219 (32.3) 105 (16.3)
≥ 25 g/day 72 (10.6) 135 (20.9) 59.096 0.000
Total cholesterol (mmol/L) 4.31 ± 0.91 4.71 ± 1.01 -7.485 0.000
Triglycerides (mmol/L) 1.00 (0.65) 1.01 (0.64) -1.1670 0.243
HDL-C (mmol/L) 1.65 ± 0.40 1.88 ± 0.49 -9.271 0.000
LDL-C (mmol/L) 2.55 ± 0.75 2.62 ± 0.76 -1.663 0.097
Apolipoprotein (Apo) AI (g/L) 1.29 ± 0.31 1.41 ± 0.28 -7.067 0.000
ApoB (g/L) 0.84 ± 0.22 0.89 ± 0.23 -4.134 0.000
ApoAI/ApoB 1.65 ± 0.70 1.68 ± 0.57 -4.484 0.628
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of TG was presented as median (interquartile range). The
difference between the two ethnic groups was determined by the Wilcoxon-Mann-Whitney test.
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GA genotype is heterozygote for the absence and pre-
sence of the site (bands at 525-, 302- and 223-bp), and
AA genotype is homozygote for the presence of the site
(bands at 302- and 223-bp; Figure 2).
Genotypic and allelic frequencies
Table 2 gives the genotypic and allelic frequencies of
V825I polymorphism in the ABCA1 gene. The fre-
quency of G and A alleles was 57.4% and 42.6% in Bai
Ku Yao, and 57.7% and 42.3% in Han (P > 0.05); respec-
tively. The frequency of GG, GA and AA genotypes was
33.7%, 47.4% and 18.9% in Bai Ku Yao, and 33.4%,
48.6% and 18.0% in Han (P > 0.05); respectively. There
was no significant difference in the genotypic and allelic
frequencies between males and females in both ethnic
groups.
The nucleotide sequence of V825I polymorphism
The results were shown as GG, GA and AA genotypes
by PCR-RFLP, the GG, GA and AA genotypes were also
confirmed by sequencing (Figure 3); respectively.
Genotypes and serum lipid levels
As shown in Table 3, the levels of TC in Bai Ku Yao but
not in Han was different among the GG, GA and AA
Figure 1 Electrophoresis of PCR products of the samples.L a n eM ,1 0 0b pm a r k e rl a d d e r ;l a n e s1 - 5, samples. The 525 bp bands are the
target genes.
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higher serum TC levels than the subjects with GG and
GA genotypes.
The levels of HDL-C and ApoAI in Han but not in
Bai Ku Yao was different among the GG, GA and AA
genotypes (P < 0.05), the subjects with AA genotype had
lower serum HDL-C and ApoAI levels than the subjects
with GG and GA genotypes, but these findings were
restricted to males but not females.
Relative factors for serum lipid parameters
Multivariate linear regression analysis showed that the
levels of TC in Bai Ku Yao and HDL-C and ApoAI in
Han were correlated with genotypes (P < 0.05 for all;
Table 4). When the multivariate linear regression analy-
sis was performed according to sex in both ethnic
groups; respectively, we found that the levels of HDL-C
and ApoAI in Han were correlated with genotypes in
males but not in females (P < 0.05 for each, Table 5).
Figure 2 Genotyping of V825I polymorphism in the ABCA1 gene. Lane M, 100 bp marker ladder; lanes 1 and 2, GG genotype (525 bp);
lanes 3 and 4, GA genotype (525-, 323- and 202-bp); and lanes 5 and 6, AA genotype (323- and 202-bp).
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age, BMI, alcohol consumption, cigarette smoking, and
blood pressure in both ethnic groups (Tables 4 and 5).
Discussion
In the present study, we reported the serum lipid pro-
files in two Chinese populations, Bai Ku Yao and Han.
It offered evidence again to confirm that the levels of
serum TC, HDL-C, ApoAI and ApoB were lower in Bai
Ku Yao than in Han. The findings were also emphasized
in a previous study [34]. There was no significant differ-
ence in the levels of serum TG, LDL-C and the ratio of
ApoAI to ApoB between the two ethnic groups. It has
been confirmed that dyslipidemia is a condition caused
by multifactors, including hereditary and modifiabled
risk factors. Bai Ku Yao is an isolated subgroup of the
Yao minority in China. They reside in two villages, Lihu
and Baxu, Nandan County. Both villages are typical
infertile mountain area. The main agricultural crops are
corn and paddy. Strict intra-ethnic marriages and special
diet have been performed in this population from time
immemorial. Therefore, the hereditary characteristics
and genotypes of some lipid metabolism-related genes
in this population may be different from those in Han
Chinese.
Table 2 Genotypic and allelic frequencies of the ABCA1
V825I polymorphism between the Bai Ku Yao and Han
populations [n (%)]
Group n Genotype Allele
GG GA AA G A
Bai Ku Yao 677 228
(33.7)
321
(47.4)
128
(18.9)
777
(57.4)
577
(42.6)
Han
Chinese
646 216
(33.4)
314
(48.6)
116
(18.0)
746
(57.7)
546
(42.3)
c
2 - 0.265 0.034
P - 0.876 0.854
Bai Ku Yao
Male 324 110
(34.0)
153
(47.2)
61 (18.8) 373
(57.6)
275
(42.4)
Female 353 118
(33.4)
168
(47.6)
67 (19.0) 404
(57.2)
302
(42.8)
c
2 - 0.210 0.016
P - 0.990 0.900
Han
Chinese
Male 315 104
(33.0)
151
(48.9)
57 (18.1) 359
(57.5)
265
(42.5)
Female 331 112
(33.8)
160
(48.3)
59 (17.8) 384
(58.0)
278
(42.0)
c
2 - 0.490 0.030
P - 0.976 0.863
Figure 3 A part of the nucleotide sequence of the ABCA1 V825I polymorphism. (A) GG genotype; (B) GA genotype; (C) AA genotype.
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Yao (42.6%) was similar to that in Han Chinese (42.3%).
There was also no significant difference in the genotypic
and allelic frequencies between males and females in the
both ethnic groups. However, the frequency of A allele
in our study populations was higher than that in a pre-
vious report from the Han Chinese [29]. Li et al.[ 2 9 ]
reported that the frequency of A allele was 32.3% in 386
Han healthy individuals, and the frequency of GG, GA
and AA genetypes was 44.9%, 45.5% and 9.6%; respec-
tively. Tan et al. [31] showed that the frequency of A
allele in male healthy controls in the Singapore Chinese,
Malays and Indians was 41.7%, 24.9% and 5.5%; respec-
tively. In a total of 515 Chinese, 112 Malay, 166 Indian
male CHD patients, the frequency of A allele was 44.6%,
31.8% and 8.4%; respectively. However, the frequency of
A allele in European was very low. It was 6% in Danish
general population, 5% in low and 8% in high HDL-C
subjects [26,28], 5.6% in participants from Belfast
(Northern Ireland) and 6% in those from Glasgow (Scot-
land) [46], and 8.1% in Dutch [30]. These results indi-
cate that the prevalence of the A allele variation of
Table 3 Genotypic frequencies of the ABCA1 V825I polymorphism and serum lipid levels between the Bai Ku Yao and
Han populations
Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L) ApoAI/ApoB
Bai Ku Yao
GG 228 4.28 ± 0.79 1.09 (0.80) 1.63 ± 0.39 2.52 ± 0.65 1.30 ± 0.34 0.84 ± 0.21 1.65 ± 0.69
GA 321 4.26 ± 0.82 0.96 (0.61) 1.64 ± 0.41 2.52 ± 0.68 1.28 ± 0.29 0.83 ± 0.22 1.64 ± 0.63
AA 128 4.52 ± 1.26 0.95 (0.61) 1.72 ± 0.45 2.69 ± 1.04 1.33 ± 0.35 0.86 ± 0.26 1.73 ± 0.91
F - 3.839 4.621 2.073 2.358 1.460 0.663 0.862
P - 0.022 0.099 0.127 0.095 0.233 0.516 0.423
Male
GG 110 4.29 ± 0.80 1.25 (0.91) 1.65 ± 045 2.43 ± 0.68 1.36 ± 0.39 0.82 ± 0.21 1.81 ± 0.86
GA 153 4.26 ± 0.88 1.00 (0.66) 1.67 ± 0.45 2.47 ± 0.73 1.32 ± 0.33 081 ± 021 1.76 ± 0.74
AA 61 4.53 ± 1.62 1.02 (0.68) 1.74 ± 0.56 2.63 ± 1.33 1.40 ± 0.44 0.83 ± 0.30 1.96 ± 1.19
F - 1.850 4.969 0.974 1.377 1.040 0.081 1.370
P - 0.159 0.083 0.379 0.254 0.355 0.922 0.256
Female
GG 118 4.26 ± 0.80 0.97(0.62) 1.60 ± 0.33 2.59 ± 0.62 1.25 ± 0.26 0.87 ± 0.20 1.50 ± 0.44
GA 168 4.26 ± 0.77 0.94(0.56) 1.62 ± 0.36 2.57 ± 0.63 1.24 ± 0.25 0.85 ± 0.22 1.53 ± 0.47
AA 67 4.50 ± 0.80 0.92(0.49) 1.69 ± 0.31 2.73 ± 0.68 1.27 ± 0.22 0.89 ± 0.20 1.51 ± 0.45
F - 2.860 0.595 1.530 2.080 0.474 1.150 0.578
P - 0.059 0.743 0.220 0.126 0.623 0.320 0.560
Han Chinese
GG 216 4.77 ± 0.99 1.00 (0.57) 1.92 ± 0.51 2.61 ± 0.72 1.43 ± 0.27 0.89 ± 0.22 1.70 ± 0.58
GA 314 4.71 ± 1.06 1.01 (0.68) 1.90 ± 0.48 2.62 ± 0.81 1.42 ± 0.28 0.89 ± 0.24 1.69 ± 0.57
AA 116 4.63 ± 0.90 1.02 (0.70) 1.78 ± 0.48 2.64 ± 0.67 1.36 ± 0.27 0.90 ± 0.21 1.58 ± 0.51
F - 0.600 0.682 3.797 0.190 3.650 0.220 1.930
P - 0.540 0.711 0.023 0.674 0.027 0.800 0.145
Male
GG 104 4.77 ± 1.03 1.01 (0.59) 1.89 ± 0.55 2.62 ± 0.73 1.42 ± 0.30 0.90 ± 0.23 1.69 ± 0.68
GA 154 4.59 ± 1.13 1.01 (0.64) 1.80 ± 0.49 2.56 ± 0.86 1.36 ± 0.29 0.87 ± 0.25 1.68 ± 0.61
AA 57 4.50 ± 1.04 1.03 (0.78) 1.71 ± 0.49 2.58 ± 0.72 1.32 ± 0.30 0.88 ± 0.22 1.61 ± 0.59
F - 1.039 0.062 3.590 0.037 3.020 0.102 0.575
P - 0.355 0.970 0.029 0.964 0.049 0.903 0.564
Female
GG 112 4.72 ± 0.96 0.96 (0.56) 1.94 ± 0.47 2.59 ± 0.71 1.43 ± 0.24 0.89 ± 0.21 1.70 ± 0.48
GA 160 4.83 ± 0.97 1.02 (0.77) 1.99 ± 0.45 2.68 ± 0.75 1.43 ± 0.26 0.91 ± 0.22 1.72 ± 0.53
AA 59 4.76 ± 0.75 0.99(0.58) 1.85 ± 0.47 2.70 ± 0.63 1.39 ± 0.23 0.93 ± 0.20 1.55 ± 0.42
F - 0.390 1.182 2.150 0.538 2.640 0.760 2.133
P - 0.677 0.554 0.118 0.585 0.073 0.469 0.120
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B. The value of TG was presented as median (interquartile range). The difference
among the genotypes was determined by the Kruskal-Wallis test.
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Page 8 of 14Table 4 Correlative factors for serum lipid parameters between the Bai Ku Yao and Han populations
Lipid parameter Relative factor Standardized coefficient Standard error tP
Bai plus Han
TC Body mass index 0.100 0.150 2.318 0.021
Age 0.194 0.002 7.234 0.000
Ethnic group -1.159 0.050 -6.200 0.001
Diastolic blood pressure 0.094 0.003 3.400 0.001
Weight 0.164 0.006 0.164 0.000
Sex 0.087 0.061 0.087 0.005
TG Weight 0.216 0.004 7.889 0.000
Alcohol consumption 0.114 0.042 4.168 0.000
HDL-C Age 0.211 0.001 8.214 0.000
Ethnic group -0.235 0.023 -9.336 0.000
Alcohol consumption 0.233 0.018 8.246 0.000
Sex 0.127 0.026 4.541 0.000
Body mass index -0.069 0.004 -2.689 0.007
LDL-C Body mass index 0.093 0.012 2.097 0.036
Age 0.188 0.001 6.975 0.000
Alcohol consumption -0.090 0.029 -3.092 0.002
Weight 0.209 0.004 4.412 0.000
Sex 0.084 0.051 2.491 0.013
ApoAI Age 0.221 0.001 8.308 0.000
Alcohol consumption 0.230 0.012 8.126 0.000
Ethnic group -0.171 0.015 -6.759 0.000
Diastolic blood pressure 0.061 0.001 2.272 0.023
Sex 0.057 0.017 2.021 0.044
ApoB Body mass index 0.237 0.002 8.922 0.000
Age 0.160 0.000 5.999 0.000
Ethnic group -0.087 0.012 -3.393 0.001
Diastolic blood pressure 0.105 0.001 3.784 0.000
Sex 0.081 0.012 3.098 0.002
ApoAI/ApoB Alcohol consumption 0.165 0.023 6.103 0.000
Body mass index -0.155 0.006 -5.722 0.000
Bai Ku Yao
TC Body mass index 0.216 0.014 5.821 0.000
Age 0.139 0.002 3.730 0.000
Genotype 0.076 0.048 2.051 0.041
TG Alcohol consumption 0.197 0.068 4.194 0.000
Body mass index 0.133 0.016 3.505 0.000
Sex -0.154 0.099 -3.099 0.002
Smoking -0.125 0.066 -2.485 0.013
HDL-C Alcohol consumption 0.204 0.022 5.502 0.000
Age 0.177 0.001 4.765 0.000
LDL-C Body mass index 0.219 0.012 5.812 0.000
Age 0.114 0.002 3.034 0.003
Alcohol consumption -0.080 0.042 -2.107 0.035
ApoAI Alcohol consumption 0.310 0.017 8.602 0.000
Age 0.167 0.001 4.639 0.000
ApoB Alcohol consumption 0.287 0.039 7.748 0.000
Body mass index -0.153 0.011 -4.138 0.000
ApoAI/ApoB Body mass index 0.207 0.004 5.463 0.000
Age 0.102 0.001 2.674 0.008
Sex 0.106 0.017 2.800 0.005
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Page 9 of 14V825I in the ABCA1 gene may have an ethnic
specificity.
The present study also demonstrated that there was a
significant association between the A allele and
increased serum TC levels in the Bai Ku Yao population
and decreased serum HDL-C and ApoAI levels in the
male Han population. Conversely, several previous stu-
dies found that the V825I polymorphism in the ABCA1
gene was associated with increased serum HDL-C levels
[26-29]. Frikke-Schmidt et al. [26,28] showed that the A
allele carriers had an increased tendency of HDL-C
levels in female individuals from the Danish general
population but not in males. They thought that the lack
of significant association in men for V825I was partly
due to less-significant effects on HDL-C in men. Kyria-
kou et al. [27] found that the 825I/825I homozygotes in
European ancestry CHD patients had higher mean
HDL-C levels than 825V/825I heterozygotes who in
turn had higher mean HDL-C levels than 825V/825V
homozygotes. The relationships were still observed after
adjusting for age, gender, smoking, BMI, hypertension,
type 1 diabetes, type 2 diabetes and family history of
CHD (P = 0.048). In addition, age of symptom onset in
825I/825I homozygotes was 2.71 years higher than that
in 825V/825I heterozygotes and 3.76 years higher than
that in 825V/825V homozygotes. Li et al. [29] found
that the V825I polymorphism may affect ApoAI levels
in Han Chinese population, but the influence depended
on the haplotype generated from V825I and R1587K.
The IK carriers had lower serum ApoAI levels than the
VR carriers. In the current study, the association of
V825I polymorphism and serum ApoAI levels, to some
extent at least, was in agreement with a previous study
in Han Chinese [29], but the influence on decreased
serum HDL-C level in Han Chinese was reverse to that
from Danish general population and European ancestry
population [26-29]. However, several previous reports
failed to find a significant association between the V825I
polymorphism in the ABCA1 gene and serum HDL-C
levels [30-33]. Clee et al. [30] showed that there was no
significant difference in the plasma HDL-C levels
between the A carriers and noncarriers in CHD patients
in a Dutch cohort prospective study, but increased CHD
events was observed in the trial (P = 0.0008). Tan et al.
[31] reported that no obviously changes in serum lipid
levels were observed in G or A allele carriers in Singa-
pore CHD and CHD-free males (Chinese, Malays and
Indian), but the V825I polymorphism clearly associated
Table 4 Correlative factors for serum lipid parameters between the Bai Ku Yao and Han populations (Continued)
Diastolic blood pressure 0.094 0.001 2.365 0.018
Han Chinese
TC Age 0.254 0.002 6.807 0.000
Diastolic blood pressure 0.128 0.004 3.264 0.001
Weight 0.281 0.004 7.109 0.000
Sex 0.165 0.076 4.387 0.000
TG Weight 0.278 0.005 7.293 0.000
Alcohol consumption 0.078 0.060 2.033 0.043
HDL-C Age 0.260 0.001 7.014 0.000
Alcohol consumption 0.218 0.023 5.628 0.000
Sex 0.151 0.039 3.770 0.000
Weight -0.100 0.002 -2.606 0.009
Genotype -0.088 0.025 -2.444 0.015
LDL-C Age 0.249 0.002 6.620 0.000
Weight 0.196 0.005 3.524 0.000
Alcohol consumption -0.124 0.035 -3.299 0.001
ApoAI Age 0.307 0.001 8.091 0.000
Alcohol consumption 0.170 0.013 4.441 0.000
Sex 0.169 0.021 4.464 0.000
Diastolic blood pressure 0.085 0.001 2.231 0.026
Genotype -0.071 0.014 -1.988 0.047
ApoB Body mass index 0.261 0.003 6.957 0.000
Age 0.228 0.001 6.086 0.000
Diastolic blood pressure 0.106 0.001 2.732 0.006
ApoAI/ApoB Body mass index -0.167 0.007 -4.305 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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Lipid parameter Relative factor Standardized coefficient Standard error tP
Bai Ku Yao
Male
TC Body mass index 0.268 0.023 5.036 0.000
Age 0.130 0.007 2.434 0.015
TG Body mass index 0.216 0.031 3.973 0.000
HDL-C Alcohol consumption 0.229 0.037 5.033 0.000
Age 0.275 0.002 4.286 0.000
Body mass index -0.116 0.011 -0.201 0.028
LDL-C Body mass index 0.261 0.021 4.854 0.000
ApoAI Alcohol consumption 0.313 0.028 5.887 0.000
Age 0.187 0.001 3.519 0.000
ApoB Body mass index 0.293 0.006 5.496 0.000
ApoAI/ApoB Alcohol consumption 0.272 0.068 4.983 0.000
Body mass index -0.188 0.022 -3.449 0.001
Female
TC Body mass index 0.170 0.016 3.253 0.001
Age 0.148 0.003 2.824 0.005
TG Alcohol consumption 0.205 0.080 3.919 0.000
LDL-C Body mass index 0.168 0.013 3.209 0.001
Age 0.162 0.002 3.012 0.002
ApoAI Age 0.159 0.001 2.300 0.003
Body mass index 0.160 0.001 2.030 0.022
ApoB Systolic blood pressure 0.328 0.008 3.067 0.002
Body mass index 0.202 0.003 3.321 0.001
Weight 0.025 0.117 2.053 0.041
ApoAI/ApoB Diastolic blood pressure -0.155 0.003 -2.937 0.004
Han Chinese
Male
TC Weight 0.334 0.006 6.638 0.000
Age 0.228 0.003 4.424 0.000
Alcohol consumption 0.152 0.065 2.932 0.004
TG Weight 0.385 0.009 7.379 0.000
HDL-C Age 0.336 0.002 6.729 0.000
Alcohol consumption 0.309 0.031 6.148 0.000
Weight -0.016 0.003 -3.278 0.007
Genotype -0.131 0.035 -2.711 0.000
LDL-C Weight 0.287 0.004 5.389 0.000
Age 0.174 0.007 3.273 0.001
ApoAI Age 0.377 0.001 7.609 0.000
Alcohol consumption 0.278 0.017 5.622 0.000
Genotype -0.125 0.020 -2.599 0.010
ApoB Body mass index 0.295 0.004 5.718 0.000
Age 0.208 0.001 3.930 0.000
Smoking 0.124 0.014 2.422 0.016
Alcohol consumption 0.106 0.015 2.005 0.046
ApoAI/ApoB Age 0.118 0.020 2.100 0.037
Body mass index -0.172 0.011 -3.054 0.002
Female
TC Age 0.278 0.007 5.317 0.000
Weight 0.210 0.006 4.075 0.000
Diastolic blood pressure 0.152 0.005 2.855 0.005
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Page 11 of 14with CHD status in male Malays. The reason for these
conflicting results is not fully understood, probably
because of differences in study designs, sample size,
race, the methods used to determine serum lipid levels
and the polymorphism, as well as gene-enviromental
interactions. To our knowledge, the association of the
V825I polymorphism and serum TC levels has not been
described previously. Thus, further studies are needed to
clarify.
Our study also revealed that environmental factors play
an important role in serum lipid regulation in the two
populations [34]. Multivariate linear regression analysis
showed that sex, age, BMI, blood pressure, alcohol con-
sumption, and cigarette smoking were involved in deter-
mining serum lipid parameters. The difference in serum
lipid profiles between Bai Ku Yao and Han might partly
result from different food items and life style factors. The
staple food in Bai Ku Yao was corn and the subsidiary
foods were rice, soy, buckwheat, sweet potato, and pump-
kin products. Approximately 90% of the beverages were
corn wine and rum. The alcohol content is about 15% (v/
v). They are also accustomed to drink hempseed soup
and eat hempseed products. In contrast, the staple food
in Han was rice and the subsidiary foods were corn,
broomcorn, potato, and taro products. About 90% of the
beverage was rice wine. The content of alcohol is about
30% (v/v). A number of experimental and clinical studies
have demonstrated that the staple and subsidiary foods
a n dt h eb e v e r a g e sw e r em o r eb eneficial for serum lipid
profiles in Bai Ku Yao than in Han [47-57].
Conclusion
T h ep r e s e n ts t u d ys h o w st h a tt h e r ei sn od i f f e r e n c ei n
the genotypic and allelic frequencies between the Han
and Bai Ku Yao populations, or between males and
females in the both ethnic groups. But the V825I poly-
morphism in the ABCA1 gene is found to be associated
with male serum HDL-C and ApoAI levels in the Han,
and serum TC levels in the Bai Ku Yao populations.
The participants with AA genotype in Han male had
lower serum HDL-C and ApoAI levels than the partici-
pants with GG and GA genotypes, whereas the subjects
with AA genotype in Bai Ku Yao had higher serum TC
levels than the subjects with GG and GA genotypes.
The difference in the association of V825I polymorph-
ism and serum lipid levels between the two ethnic
groups might partly result from different ABCA1 gene-
enviromental interactions.
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